H.O. (Ewald) van Dyk MSc

Gegenereerd op 2017-07-21 08:38:36


Melanoma and other cancer cells present neoantigens in the form of peptide-MHCI complexes that are different from self antigens. We are interested in predicting exactly which of these antigens are sufficiently different from self and are likely to elicit an immuno responses in the context of immunotherapy.

We are also interested in predicting which T-cells are likely to bind which antigens. To be exact, given the amino acid sequence of the T-cell reseptor and the peptide-MHCI complex, what will be the bining affinity for the TCR-peptide-MHCI complex?

Gegenereerd op 2017-07-21 08:38:36
Additional functions and activities


Gegenereerd op 2017-07-21 08:38:36
Full name
H.O. van Dyk MSc Contact details
Hugo R. Kruytgebouw

Padualaan 8
Room Z527
The Netherlands

Phone number (direct) +31 30 253 4212
Gegenereerd op 2017-07-21 08:38:36
Last updated 29.09.2016